Search
Descriptor English: Antineoplastic Agents
Descriptor Spanish: Antineoplásicos
Descriptor Portuguese: Antineoplásicos
Descriptor French: Antinéoplasiques
Entry term(s): Agent, Anticancer
Agent, Antineoplastic
Agent, Antitumor
Agent, Cancer Chemotherapy
Agents, Anticancer
Agents, Antineoplastic
Agents, Antitumor
Agents, Cancer Chemotherapy
Agents, Chemotherapeutic Anticancer
Anticancer Agent
Anticancer Agents
Antineoplastic
Antineoplastic Agent
Antineoplastic Drug
Antineoplastic Drugs
Antineoplastics
Antitumor Agent
Antitumor Agents
Antitumor Drug
Antitumor Drugs
Cancer Chemotherapy Agent
Cancer Chemotherapy Agents
Cancer Chemotherapy Drug
Cancer Chemotherapy Drugs
Chemotherapeutic Anticancer Agents
Chemotherapeutic Anticancer Drug
Chemotherapy Agent, Cancer
Chemotherapy Agents, Cancer
Chemotherapy Drug, Cancer
Chemotherapy Drugs, Cancer
Drug, Antineoplastic
Drug, Antitumor
Drug, Cancer Chemotherapy
Drug, Chemotherapeutic Anticancer
Drugs, Antineoplastic
Drugs, Antitumor
Drugs, Cancer Chemotherapy
Tree number(s): D27.505.954.248
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000970
Scope note: Substances that inhibit or prevent the proliferation of NEOPLASMS.
Annotation: /admin: various administration procedures are available, as CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CHEMOEMBOLIZATION, THERAPEUTIC and INFUSIONS, INTRA-ARTERIAL; for combined anticancer agents, ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS is available; Manual 24.4.2.1+
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Entry Version: ANTINEOPL AGENTS
Related: Anticarcinogenic Agents MeSH
Chemoembolization, Therapeutic MeSH
Chemotherapy, Cancer, Regional Perfusion MeSH
Cytotoxins MeSH
Infusions, Intra-Arterial MeSH
Tumor Lysis Syndrome MeSH
DeCS ID: 974
Unique ID: D000970
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2020/05/27
Antineoplastic Agents - Preferred
Concept UI M0001483
Scope note Substances that inhibit or prevent the proliferation of NEOPLASMS.
Preferred term Antineoplastic Agents
Entry term(s) Agent, Anticancer
Agent, Antineoplastic
Agent, Antitumor
Agent, Cancer Chemotherapy
Agents, Anticancer
Agents, Antineoplastic
Agents, Antitumor
Agents, Cancer Chemotherapy
Agents, Chemotherapeutic Anticancer
Anticancer Agent
Anticancer Agents
Antineoplastic
Antineoplastic Agent
Antineoplastic Drug
Antineoplastic Drugs
Antineoplastics
Antitumor Agent
Antitumor Agents
Antitumor Drug
Antitumor Drugs
Cancer Chemotherapy Agent
Cancer Chemotherapy Agents
Cancer Chemotherapy Drug
Cancer Chemotherapy Drugs
Chemotherapeutic Anticancer Agents
Chemotherapeutic Anticancer Drug
Chemotherapy Agent, Cancer
Chemotherapy Agents, Cancer
Chemotherapy Drug, Cancer
Chemotherapy Drugs, Cancer
Drug, Antineoplastic
Drug, Antitumor
Drug, Cancer Chemotherapy
Drug, Chemotherapeutic Anticancer
Drugs, Antineoplastic
Drugs, Antitumor
Drugs, Cancer Chemotherapy



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey